3 Sep 2015 06:36
Circassia Pharmaceuticals has officially declared an unconditional offer for Aerocrine and extended its acceptance period until 26 June. During the acceptance period, roughly 6.5m shares have been tendered, representing 93% of shared and voting rights in Aerocrine. Circassia first made a public cas
Read more